Cargando…
GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288193/ https://www.ncbi.nlm.nih.gov/pubmed/35855749 http://dx.doi.org/10.2147/IJN.S381649 |
Ejemplares similares
-
GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma
por: Li, Yanying, et al.
Publicado: (2022) -
Enhanced Efficacy of Chemically Modified Curcumin in Experimental Periodontitis: Systemic Implications [Corrigendum]
Publicado: (2020) -
Modulated electro-hyperthermia-enhanced liposomal drug uptake by cancer cells [Corrigendum]
Publicado: (2019) -
Corrigendum to “The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma”
por: You, Jia, et al.
Publicado: (2019) -
Corrigendum to “Drug Delivery Nanoparticles in Skin Cancers”
por: Dianzani, Chiara, et al.
Publicado: (2021)